No Data
No Data
Kanghong Pharmaceutical Gets Nod for Tofacitinib Citrate Tablets' Registration
Chengdu Kanghong Pharmaceutical Group (002773.SZ): The citric acid tofacitinib sustained-release tablet has obtained the pharmaceutical registration certificate.
Chengdu Kanghong Pharmaceutical Group (002773.SZ) announced that the company recently received a notice from the National Medical Products Administration regarding the pharmaceutical...
Express News | chengdu kanghong pharmaceutical group: The company has received the pharmaceutical registration certificate.
Kanghong Pharmaceutical's Sodium Hyaluronate Eye Drops Gets Registration Certificate; Shares Down 3%
Chengdu Kanghong Pharmaceutical Group (002773.SZ): Sodium Hyaluronate Eye Drops approved for sale.
Chengdu Kanghong Pharmaceutical Group (002773.SZ) announced that the company recently received a notice issued by the National Medical Products Administration regarding...
Chengdu Kanghong Pharmaceutical Group (002773): Combixip steady growth, focusing on the progress of ophthalmic innovative drugs.
Investment highlights: Event: The company released the third quarter report of 2024, achieving revenue of 3.41 billion yuan in the first three quarters of 2024 (+13.8% year-on-year), attributable net income of 0.97 billion yuan (+18.0% year-on-year), net income excluding non-recurring items.
No Data
No Data